Sarepta Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2016
Total Assets: $424.1M
Liabilities Breakdown FY2016
Total Liabilities: $87.4M
Asset Breakdown
Total Assets: $424.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $122.4M | 28.9% |
| Accounts Receivable | $5.2M | 1.2% |
| Inventory | $12.8M | 3.0% |
| Property, Plant & Equipment | $37.8M | 8.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $8.1M | 1.9% |
| Other Assets | $237.8M | 56.1% |
Liabilities Breakdown
Total Liabilities: $87.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $29.7M | 34.0% |
| Long-Term Debt | $17.7M | 20.2% |
| Other Liabilities | $40.1M | 45.8% |